Skip to main content

Table 1 Baseline characteristics of patients by miRNA assessment set

From: Integrated analysis identifies microRNA-195 as a suppressor of Hippo-YAP pathway in colorectal cancer

 

TCGACOAD test cohort

Independent validation cohort

 

(n = 240)

(n = 60)

Gender

 Male

132

38

 Female

108

22

Age

 60 years or younger

82

22

 Older than 60 years

158

38

TNM stage

 I

39

10

 II

93

15

 III

75

28

 IV

33

7

Pathologic M stage

 M0

207

53

 M1

33

7

Nodes count

 12 or more

189

19

 Less than 12

51

41

Lymphatic invasion

 Absent

166

25

 Present

74

35

Vascular Invasion

 Absent

193

47

 Present

47

13

Follow-up time (months)

 Median

13.367

33

 Range

(0.067–141.1)

(4.0–57.0)

Preoperative serum CEA level

 <5 μg/mL

188

37

 ≥5 μg/mL

52

23

  1. Abbreviation:CEA = carcinoembryonicantigen